• Mallinckrodt Announces Top-Line Results from Terlipressin Trial americanpharmaceuticalreview
    August 16, 2019
    Mallinckrodt announced positive top-line results from its pivotal Phase 3 CONFIRM clinical study evaluating the efficacy and safety of terlipressin in 300 adults with hepatorenal syndrome type 1 (HRS-1).
  • Viking Therapeutics Announces Positive Top-Line Results of VK2809 Study americanpharmaceuticalreview
    September 20, 2018
    Viking Therapeutics announced positive top-line results from a 12-week Phase 2 study of VK2809, its novel liver-selective thyroid receptor beta agonist, in patients with non-alcoholic fatty liver disease (NAFLD) and elevated low-density lipoprotein choles
PharmaSources Customer Service